Post Malone looks a little different than he did when he first burst onto the music scene. Here’s what to know about the ...

What if the future of weight-loss drugs didn’t involve needles at all? Drugmakers are testing once-a-day pills and next-gen ...

The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The ...

The studies come as more and more women are turning to GLP-1 drugs to help them lose weight, particularly after menopause ...

Some people may be considering skipping a dose of their weight-loss medication so they can eat more on Thanksgiving, but ...

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...

Novo and Lilly just slashed prices on GLP-1 weight-loss drugs that recently cost over $1,000 a month. What happened?

The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond ...

The drug tested was Rybelsus, a pill approved only for type 2 diabetes. Like Novo's blockbusters Ozempic and Wegovy, it ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

Eli Lilly said on Friday it plans to roll out an employer-focused obesity care model early next year, aiming to expand access ...

Lilly becomes the first pharmaceutical company to hit that threshold, joining a select club of mostly tech companies.